๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitroimidazoles

โœ Scribed by C. Koch; S. Hahn; K. Rockwell; J. Covey; W. McKenna; S. Evans

Book ID
105994718
Publisher
Springer
Year
2001
Tongue
English
Weight
188 KB
Volume
48
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Class III Antiarrhythmic Activity in Viv
Class III Antiarrhythmic Activity in Vivo by Selective Blockade of the Slowly Activating Cardiac Delayed Rectifier Potassium Current I Ks by ( R )-2-(2,4- Trifluoromethyl)- N -[2-oxo-5-phenyl- 1-(2,2,2-trifluoroethyl)-2,3-dihydro- 1 H -benzo[ e ][1,4]diazepin-3-yl]acetamide
โœ Selnick, Harold G.; Liverton, Nigel J.; Baldwin, John J.; Butcher, John W.; Clar ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› American Chemical Society ๐ŸŒ English โš– 100 KB
Development of Human Calcitonin Gene-Rel
Development of Human Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists. 1. Potent and Selective Small Molecule CGRP Antagonists. 1-[ N 2 -[3,5-Dibromo- N -[[4-(3,4-dihydro-2(1 H )-oxoquinazolin-3-yl)-1- piperidinyl]carbonyl]- d -tyrosyl]- l -lysyl]-4-(4-pyridinyl)piperazine: The First CGRP Antagonist for Clinical Trials in Acute Migraine โ€ 
โœ Rudolf, Klaus; Eberlein, Wolfgang; Engel, Wolfhard; Pieper, Helmut; Entzeroth, M ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› American Chemical Society ๐ŸŒ English โš– 222 KB